Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

NCT05669534 is registered in ClinicalTrials.gov with University of Connecticut as lead sponsor.

NCT NCT05669534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05669534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
Lead sponsor
University of Connecticut
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2023
Completion date
January 1, 2027
Enrollment
256 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, opioid use disorder